Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases
Clinical trial NCT04610684 · TERMINATED
Trial details
- NCT number
- NCT04610684
- Sponsor
- Jeffrey Clarke
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-05
- Primary completion
- 2022-07-15
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.